Evidence map›Paper›PMID 19574958›Full record

ArticleThe EMBO journal2009

Mal connects TLR2 to PI3Kinase activation and phagocyte polarization.

Sandra Santos-Sierra, Sachin D Deshmukh, Julia Kalnitski, Peter Küenzi, Matthias P Wymann, Douglas T Golenbock, Philipp Henneke

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 116 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. AKT Isoforms in Macrophage Activation, Polarization, and Survival.Current topics in microbiology and immunology · 2022
    Article
  12. Article
  13. Article
  14. Strategies for Biomaterial-Based Spinal Cord Injury RepairFrontiers in bioengineering and biotechnology · 2021
    Review
  15. TIRAP in the Mechanism of Inflammation.Frontiers in immunology · 2021
    Review
  16. Article
  17. Frontiers in microbiology · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Sandra Santos-SierraCenter for Pediatrics and Adolescent Medicine and Centre of Chronic Immunodeficiency, University Medical Center Freiburg, Freiburg 79106, Germany.
Sachin D Deshmukh
Julia Kalnitski
Peter Küenzi
Matthias P Wymann
Douglas T Golenbock
Philipp Henneke
University Medical Center Freiburg · DEUniversity of Basel · CHUniversity of Massachusetts Chan Medical School · US

Funding

Group B. Streptococci and Toll-like ReceptorsR01AI052455 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GOLENBOCK, DOUGLAS T · 2002 to 2012
$4.2M
NIAID NIH HHS R01 AI052455NIAID NIH HHS R0I AI052455-06A1
6 · The paper itself

Abstract

The recognition of bacterial lipoproteins by toll-like receptor (TLR) 2 is pivotal for inflammation initiation and control in many bacterial infections. TLR2-dependent signalling is currently believed to essentially require both adaptor proteins MyD88 (myeloid differentiation primary response gene 88) and Mal/TIRAP (MyD88-adapter-like/TIR-domain-containing adaptor protein). TLR2-dependent, but MyD88-independent responses have not been described yet. We report here on a novel-signalling pathway downstream of TLR2, which does not adhere to the established model. On stimulation of the TLR2/6 heterodimer with diacylated bacterial lipoproteins, Mal directly interacts with the regulatory subunit of phosphoinositide 3-kinase (PI3K), p85alpha, in an inducible fashion. The Mal-p85alpha interaction drives PI3K-dependent phosphorylation of Akt, phosphatidylinositol(3,4,5)P3 (PIP(3)) generation and macrophage polarization. MyD88 is not essential for PI3K activation and Akt phosphorylation; however, cooperates with Mal for PIP(3) formation and accumulation at the leading edge. In contrast to TLR2/6, TLR2/1 does not require Mal or MyD88 for Akt phosphorylation. Hence, Mal specifically connects TLR2/6 to PI3K activation, PIP(3) generation and macrophage polarization.

Indexed as

Signal TransductionAnimalsCell LineCell PolarityHumansMacrophagesMembrane GlycoproteinsMiceMinor Histocompatibility AntigensMyeloid Differentiation Factor 88Phosphotransferases (Alcohol Group Acceptor)Receptors, Interleukin-1Toll-Like Receptor 2Membrane GlycoproteinsMinor Histocompatibility AntigensMYD88 protein, humanMyeloid Differentiation Factor 88phosphatidylinositol phosphate 4-kinasePhosphotransferases (Alcohol Group Acceptor)Receptors, Interleukin-1TIRAP protein, humanTLR2 protein, humanToll-Like Receptor 2

Identifiers

PMID19574958
PMCPMC2718282
OpenAlexW1966210473

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.